FibroGen (FGEN) announces positive top-line data from the study of its investigational candidate roxadustat, which is being evaluated to treat chemoth...
from Entrepreneur: Latest Articles FibroGen (FGEN) announces positive top-line data from the study of its investigational candidate roxadustat, which is being evaluated to treat chemoth... https://ift.tt/eA8V8J August 26, 2021 at 10:26PMhttps://https://ift.tt/3DkID4Q
0 Comments